# |
PMID |
Sentence |
1 |
11178400
|
[Abnormal toxicity - a relevant safety test under GLP- and GMP-conditions in the production of vaccines?]
|
2 |
11178400
|
This paper deals with the relevance of abnormal toxicity after the introduction of GMP- and GLP-conditions in the production of veterinary biologicals.
|
3 |
11178400
|
[Abnormal toxicity - a relevant safety test under GLP- and GMP-conditions in the production of vaccines?]
|
4 |
11178400
|
This paper deals with the relevance of abnormal toxicity after the introduction of GMP- and GLP-conditions in the production of veterinary biologicals.
|
5 |
11178440
|
The purpose of this project was to investigate the relevance of ATT after the introduction of GMP- and GLP-principles in the manufacturing of biological products.
|
6 |
15496321
|
Thus it has become imperative that, in concert with other quality control measures, a potency test be utilized for the GMP/GLP lot-release of DC products for preclinical and clinical studies.
|
7 |
16519970
|
Additional purification of GMP rPA by anion exchange chromatography separated and enriched the two principal isoforms.
|
8 |
16519970
|
There was no significant difference in the biological activity of each isoform compared to GMP rPA when analyzed in the presence of lethal factor using a macrophage lysis assay.
|
9 |
16519970
|
Additional purification of GMP rPA by anion exchange chromatography separated and enriched the two principal isoforms.
|
10 |
16519970
|
There was no significant difference in the biological activity of each isoform compared to GMP rPA when analyzed in the presence of lethal factor using a macrophage lysis assay.
|
11 |
25483693
|
To meet the time constraint imposed on this project, we used a distributed R&D model involving experts in the fields of protein engineering and production, bioinformatics, peptide synthesis/design and GMP/GLP manufacturing and testing standards.
|